MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202411003811 A) filed by Premas Biotech Pvt. Ltd., Manesar, Haryana, on Jan. 19, 2024, for 'vlp, vlp-rna complex and recombinant expression platform for expression thereof.'
Inventor(s) include Prabuddha Kumar Kundu; Kajal Arora; Nupur Mehrotra Arora; Sourav Singha Roy; and Sameena Khan.
The application for the patent was published on Aug. 1, under issue no. 31/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides a versatile recombinant expression platform for expression of multi-antigen VLPs and VLP-RNA complexes particularly, VLP-mRNA complexes. The present invention provides a VLP-mRNA complex encapsulating mRNA inside VLP with increased thermostability and protection from ribonucleases, hence, have a shelf life up to 2 years, increased template copy number with enhanced therapeutic outcome. The multivalent VLPs and complexes of the present invention have great potential applications against one or more respiratory, bacteriological and oncological diseases."
Disclaimer: Curated by HT Syndication.
